Back to Bills

Declare Glioblastoma Awareness Day

Full Title:
Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day".

Summary#

This resolution asks the House of Representatives to support designating July 15, 2026, as "Glioblastoma Awareness Day." It is a non‑binding, symbolic statement that encourages awareness, honors people affected by glioblastoma, and urges more research and collaboration. The bill does not create new programs or authorize spending.

  • Main change: the House formally expresses support for a one‑day awareness designation on July 15, 2026.
  • Encourages: increased public awareness of glioblastoma and recognition of patients, families, and caregivers.
  • Supports: efforts to develop better treatments, and recognizes the importance of molecular biomarker testing for diagnosis and treatment.
  • Urges: collaboration among government, private, and nonprofit groups and continued investments in research, including through the Glioblastoma Therapeutics Network (GTN).
  • Nature of the action: symbolic resolution (no legal or funding mandates included).

What it means for you#

  • Patients and caregivers: The resolution offers public recognition and could raise awareness of patient needs. It does not change medical care, insurance coverage, or access to treatments.
  • Researchers and research programs: The text encourages collaboration and investment, and highlights the GTN, but it does not provide funding or require research changes.
  • Healthcare providers: The resolution emphasizes the importance of molecular biomarker testing for glioblastoma, but it does not change clinical rules, reimbursement, or testing requirements.
  • General public: The day is intended to increase awareness about how serious glioblastoma is and the need for research and support services.
  • Government agencies and lawmakers: The resolution urges collaborative approaches and continued investments but does not require agencies to take specific actions or allocate money.

Expenses#

No publicly available information.

  • The resolution itself does not list any new spending, fees, or programs.
  • There is no fiscal note or budget estimate attached to the text provided.
  • If any public outreach or events take place because of the day, those costs would depend on subsequent actions by agencies, non‑profits, or private groups; the resolution does not authorize or fund such activities.

Proponents' View#

The bill appears intended to do the following:

  • Raise public awareness of glioblastoma’s severity and the urgent medical needs of patients.
  • Honor people who have died from, or are living with, glioblastoma and acknowledge caregivers’ roles.
  • Encourage research, cooperation, and investment to improve treatments and quality of life for patients.
  • Highlight the importance of molecular biomarker testing for accurate diagnosis and treatment planning.
  • Support use of existing research structures such as the Glioblastoma Therapeutics Network as a way to speed new therapies from lab to early clinical trials.

Opponents' View#

One could raise these concerns based on the text of the resolution:

  • The resolution is symbolic and does not create funding, programs, or legal requirements to address the problems it describes.
  • It does not specify who would carry out awareness activities, how they would be funded, or how success would be measured.
  • The designation covers a single day and does not prescribe ongoing actions or timelines for research or treatment improvements.
  • The resolution notes needs (for example, few approved treatments and low survival rates) but does not lay out specific policy steps to address regulatory, coverage, or research funding barriers.